tiprankstipranks

Matt Miksic Profile - Barclays Analyst

501 Followers
tipranks
Matt Miksic

Matt Miksic
Barclays

Wall Street Analyst
#3,819 out of 12,298 Wall Street Analysts
#7,815 out of 28,790 experts

Success Rate

50%
240 out of 479 ratings made a profit

Average Return

+2.30%
Average return per rating
Time Frame
1 Year
Compare to
No Benchmark
Copying Matt Miksic's trades since 2013 and holding each position for 1 Year would result in 50.10% of your transactions generating a profit, with an average return of 2.3% per rating.

Stock Rating Distribution

895Ratings
74.30% Buy
20.22% Hold
5.47% Sell
Distribution of Matt Miksic's ratings

Additional Information

Main Sector:Healthcare
Geo Coverage:
United States

Best Rating

Stock:
Organogenesis Holdings
(ORGO)
Rating:Buy
Date:May 12, 2020 - May 12, 2021
Return:+397.90%
The most profitable rating made by Matt Miksic

Matt Miksic's Stock Coverage

Company
Date
Position
Action
Price Target
No. of Ratings
Success Rate
Avg. Return
Orthofix Medical
Mar 14, 2013
Hold
Reiterated
$43.00
(315.86% Upside)
3Ratings
0.00%
Conmed
Jul 24, 2013
Hold
Assigned
$36.00
(2.48% Upside)
2Ratings
0.00%
Smith & Nephew Snats
Nov 03, 2014
Hold
Reiterated
$37.00
(19.94% Upside)
1Ratings
0.00%
Vyome Holdings
Oct 31, 2016
Buy
Initiated
$21.00
(813.04% Upside)
1Ratings
0.00%
MiMedx Group
Dec 12, 2016
Sell
Initiated
$9.00
(138.10% Upside)
1Ratings
0.00%
Envista Holdings
Sep 30, 2021
Buy
Initiated
$55.00
(140.49% Upside)
1Ratings
0%
-21.50%
Integra Lifesciences
Nov 03, 2021
Buy
Reiterated
$87.00
(395.44% Upside)
25Ratings
75%
+22.82%
Henry Schein
Feb 16, 2022
Buy
Reiterated
$100.00
(31.06% Upside)
3Ratings
50%
+0.85%
DENTSPLY SIRONA
Mar 01, 2022
Buy
Reiterated
$67.00
(578.14% Upside)
5Ratings
0%
-40.35%
Sotera Health
Mar 02, 2022
Buy
Reiterated
$28.00
(79.83% Upside)
3Ratings
0%
-14.10%
List of latest recommendations made by Matt Miksic. Click to expand and see Matt Miksic's performance on a particular stock
Disclaimer: TipRanks collects analysts’ ratings and price targets by scanning publicly available reports on financial websites and by receiving reports from analysts, firms, or customers. The information and statistics displayed might not be accurate, complete, or up-to-date. The analyst ratings provided are the sole responsibility of the source publication. TipRanks holds no liability over the analysts' information, price targets, ratings, or opinions expressed.
Advertisement
Send Us Reports
If you receive reports that you think we are missing, we will thank you with a free Ultimate upgrade!
Learn More >

About Analyst Ratings

About Analyst Ratings
Analyst ratings represent professional recommendations - Buy, Hold, or Sell - issued for a specific stock. Each rating reflects the analyst’s view at the time of publication and is tracked to measure historical performance.
Ratings Count
The total number of analyst ratings (Buy, Hold, and Sell) issued for the stock. This includes all published recommendations, even those not used in performance calculations.
Performance Calculation
To ensure accuracy and prevent duplication, only certain ratings are included in performance metrics:
•  
One rating per analyst per month: If an analyst publishes more than one rating in a month, only the first is counted.
•  
Updated ratings end prior ones: If the analyst changes their stance during that month (for example, from Buy to Sell), performance tracking for the earlier rating stops immediately on the update date, and the new rating begins tracking from that point forward.
•  
Hold ratings excluded: Hold recommendations are displayed on the chart but are not counted in performance or return calculations.
Example
If an analyst rates a stock Buy on April 1 and changes it to Sell on April 20, the Buy rating’s performance is measured from April 1 to April 20. From April 20 onward, only the Sell rating is tracked.
Success Rate
Indicates the percentage of performance-accounted ratings that generated a positive return during their active period. For example, if 6 out of 17 accounted ratings were profitable, the success rate is 35%.
Average Return
Represents the mean return per active rating - showing the average gain or loss an analyst’s recommendation produced while it was active.

Matt Miksic activity FAQ

What is the performance of Matt Miksic's recommendations?
The percentage of profitable recommendations made by Matt Miksic is 50%, and the average return per transaction is 2.30%.
    What stocks does Matt Miksic cover?
    Matt Miksic mostly covers JNJ ,MDT ,EW stocks.
      What was Matt Miksic's most profitable rating?
      Matt Miksic’s most profitable ratings was a buy on ORGO stock on May 12, 2020 - May 12, 2021. The return on the trade was +397.90%.
        Where can I see a list of stock analyst ratings?
        You can see a list of daily stock analyst ratings here.
          What are the most recommended stocks by analysts?
          You can see a list of the most recommended stocks by analysts here